Grey Fox Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27M Sell
1,102
-87
-7% -$103K 0.19% 69
2026
Q2
$1.43M Buy
1,189
+180
+18% +$184K 0.22% 60
2026
Q1
$928K Buy
1,009
+50
+5% +$50.7K 0.18% 68
2025
Q4
$1.03M Sell
959
-43
-4% -$41.1K 0.21% 63
2025
Q3
$765K Buy
1,002
+5
+0.5% +$3.72K 0.16% 71
2025
Q2
$777K Hold
997
– – 0.19% 69
2025
Q1
$823K Buy
997
+44
+5% +$36.6K 0.22% 65
2024
Q4
$735K Buy
953
+1
+0.1% +$828 0.2% 72
2024
Q3
$844K Hold
952
– – 0.24% 61
2024
Q2
$862K Buy
+952
New +$762K 0.3% 50
2023
Q2
– Sell
-138
Closed -$47.4K – 333
2023
Q1
$47.4K Buy
138
+9
+7% +$3.04K 0.03% 189
2022
Q4
$47.2K Buy
+129
New +$45.7K 0.03% 170

Other funds holding LLY

Grey Fox Wealth Advisors's LLY Position: Q3 2026 in Review

Grey Fox Wealth Advisors reduced its Eli Lilly (LLY) stake by 7.3% in Q3 2026, selling an estimated $103K and leaving 1,102 shares worth $1.27M. The position accounts for 0.19% of the portfolio, ranked #69.

Grey Fox Wealth Advisors first reported a position in LLY in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.43M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Grey Fox Wealth Advisors held 1,102 shares of Eli Lilly worth $1.27M as of Q3 2026.
  • Grey Fox Wealth Advisors sold 87 Eli Lilly shares in Q3 2026, an estimated $103K.
  • Eli Lilly made up 0.19% of Grey Fox Wealth Advisors's portfolio in Q3 2026, its #69 holding.
  • Grey Fox Wealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 12 quarters since.
  • Grey Fox Wealth Advisors's Eli Lilly position peaked at $1.43M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Grey Fox Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.